Calling all patients with chronic liver disease... help us to help you better!

Patients with chronic liver disease have a higher risk of developing liver cancer. We are looking for participants with chronic liver disease to join our research study to develop better diagnostic tools and strategies for early liver cancer detection.

Who is eligible to take part in this study? 

Patients 50 years old and above

Have one of the following chronic liver diseases 

If selected, participants can expect to:

  • Receive at 6-monthly intervals for up to 7 visits:

    • Ultrasound

    • Liver function test

    • Other blood tests

  • Receive CT scans or MRI as indicated

  • Receive transport reimbursement if the investigations or scans are done at external clinics

  • Complete a set of questionnaires after every visit

  • Provide bio-samples (blood, urine and stool) for research for up to 7 visits 

Interested to join this study?

Contact our study team members to find out more:

Tel: +65 6306 5463


This study is led by Professor Pierce Chow, Senior Consultant from the Division of Surgery & Surgical Oncology at National Cancer Centre Singapore (NCCS), and in collaboration with Changi General Hospital (CGH), National University Hospital (NUH), Singapore General Hospital (SGH), SingHealth Polyclinics (SHP), Sengkang General Hospital (SKH) and Tan Tock Seng Hospital (TTSH). SGH, CGH, SKH, NCCS and SHP are members of the SingHealth group.